CN106957255A - Methylisoindoline of 5 bromines of one kind (R) N Boc 1 and its preparation method and application - Google Patents

Methylisoindoline of 5 bromines of one kind (R) N Boc 1 and its preparation method and application Download PDF

Info

Publication number
CN106957255A
CN106957255A CN201710191789.7A CN201710191789A CN106957255A CN 106957255 A CN106957255 A CN 106957255A CN 201710191789 A CN201710191789 A CN 201710191789A CN 106957255 A CN106957255 A CN 106957255A
Authority
CN
China
Prior art keywords
bromo
preparation
methylisoindolines
boc
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710191789.7A
Other languages
Chinese (zh)
Other versions
CN106957255B (en
Inventor
吴天俊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHANGHAI BALMXY PHARMACEUTICAL Co Ltd
Original Assignee
SHANGHAI BALMXY PHARMACEUTICAL Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI BALMXY PHARMACEUTICAL Co Ltd filed Critical SHANGHAI BALMXY PHARMACEUTICAL Co Ltd
Priority to CN201710191789.7A priority Critical patent/CN106957255B/en
Publication of CN106957255A publication Critical patent/CN106957255A/en
Application granted granted Critical
Publication of CN106957255B publication Critical patent/CN106957255B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

The invention provides methylisoindoline of 5 bromines of one kind (R) N Boc 1 and its preparation method and application; (R) 4 bromine α phenyl ethylamines lewis acid effect under with polyformaldehyde reaction; obtain the methylisoindoline of (R) 5 bromine 1; and then the methylisoindoline of 5 bromines of (R) N Boc 1 is protected to secondary amino group using tertbutyloxycarbonyl; the cyclic method and step novel and unique; easily operated, yield is higher.Split the bromine α phenyl ethylamines of preparing raw material (R) 4 for obtaining chirality first using resolution reagent, and then prepare the methylisoindoline of (R) 5 bromine 1, allow to that the scale of construction is greatly reduced, the scale of construction is significantly reduced, the fractionation of whole process, which is wasted, also significantly to be reduced.The raw material of the whole preparation method of the present invention is easy to get, and technological operation is simple, low cost, with higher actual application value.

Description

One kind bromo- 1- methylisoindolines of (R)-N-Boc-5- and its preparation method and application
Technical field
The invention belongs to technical field of medicine synthesis, be related to one kind bromo- 1- methylisoindolines of (R)-N-Boc-5- and its Preparation method and application.
Background technology
T-3811, English name Gatifloxacin is a carbostyril compound, its chemical entitled 1- cyclopropyl- 8- (difluoro-methoxy) -7- [(1R) -1- methyl -2,3- dihydro -1H- iso-indoles -5- bases] -4- Oxoquinoline-3-carboxylic acids, it is changed Learn structural formula as follows:
T-3811 is a kind of New-type wide-spectrum Comprecin, and it not only maintains Comprecin to G- bacterium Antibacterial activity, the antibacterial activity of G+ bacterium is also remarkably reinforced, clinic be mainly used in treat infection in respiratory system, urinary system togetherness The disease such as dye and skin, soft tissue infection.Quinolone parent nucleus 6 goes the fluorine removal can not only to improve activity, Er Qieke in its structure Reduce adverse drug reaction.
CN105837555A discloses T-3811 and its middle preparation, the T-3811 midbody compound 3 preparation flow is as follows:
The preparation flow of T-3811 is as follows:
With compound 5 it is raw material i.e. in CN105837555A, it is anti-with connection boric acid pinacol ester or triisopropyl borate ester Should, compound 4 is obtained, the bromo- 1- cyclopropyl -8- difluoro-methoxies-Isosorbide-5-Nitrae-dihydro -4- Oxoquinoline-3-carboxylic acid second of 7- is separately added into Ester, palladium catalyst and inorganic alkali solution reaction generation compound 3;And compound 2 and Jia Leisha are obtained by hydrolysis, reduction reaction Star (compound 1).It can be seen that needing that ketone is converted into alkane in final step when preparing T-3811 by midbody compound 3 Base, the step yield is relatively low.
According to the side chain of T-3811 can be learnt with backstepping T-3811 side chain can by following structure the bromo- 1- of Boc-5- Methylisoindoline conversion is obtained:
In the art, also not it has been proposed that by the high conversion preparation method of the bromo- 1- methylisoindolines of Boc-5-, The preparation of the bromo- 1- methylisoindolines of Boc-5- is the emphasis studied at present.
The content of the invention
For prior art, it is an object of the invention to provide one kind bromo- 1- methylisoindolines of (R)-N-Boc-5- and Its preparation method and application, this method are simple, and raw material is easy to get, it is easy to operate, and yield is higher, low cost, with higher reality Application value.
For up to this purpose, the present invention uses following technical scheme:
On the one hand, the present invention provides the preparation method of one kind bromo- 1- methylisoindolines of (R)-N-Boc-5-, methods described Comprise the following steps:
(1) the bromo- α-phenylethylamines of (R) -4- lewis acid effect under with polyformaldehyde reaction, obtain the bromo- 1- first of (R) -5- Base isoindoline, reaction equation is as follows:
(2) secondary amino group in the bromo- 1- methylisoindolines of (R) -5- is obtained into (R)-N- using tertbutyloxycarbonyl protection The bromo- 1- methylisoindolines of Boc-5-, reaction equation is as follows:
In the present invention, the bromo- 1- methylisoindolines of (R) -5- can be obtained by the annulation described in step (1), Its high income, it is easy to operate.The bromo- 1- methylisoindolines of (R) -5- of tertbutyloxycarbonyl protection are then obtained by step (2).
Preferably, step (1) described lewis acid is dilute sulfuric acid, anhydrous zinc chloride, alchlor, trifluoroacetic acid, tetrachloro Change in titanium or BFEE any one or at least two combination, preferred trifluoroacetic acid.
Preferably, the mol ratio of the bromo- α-phenylethylamines of (R) -4- described in step (1) and paraformaldehyde is 1:(1.5-3), for example 1:1.5、1:1.8、1:2、1:2.2、1:2.4、1:2.6、1:2.8 or 1:3.
Preferably, the temperature of step (1) described reaction be 20-60 DEG C, such as 20 DEG C, 23 DEG C, 25 DEG C, 28 DEG C, 30 DEG C, 33 DEG C, 35 DEG C, 38 DEG C, 40 DEG C, 43 DEG C, 45 DEG C, 48 DEG C, 50 DEG C, 53 DEG C, 55 DEG C, 58 DEG C or 60 DEG C.
Preferably, the solvent of step (1) described reaction be glacial acetic acid, toluene, benzene or acetonitrile in any one or at least Two kinds of combination.
Preferably, the time of step (1) described reaction is 4-7 hours, such as 4 hours, 4.5 hours, 5 hours, it is 5.5 small When, 6 hours, 6.5 hours or 7 hours.
Preferably, step (1) reaction is carried out under protective gas protection, the preferred nitrogen of protective gas.
Preferably, the bromo- α-phenylethylamines of (R) -4- described in step (1) are prepared by raw material of parabromoacetophenone.
Preferably, the preparation method of the bromo- α-phenylethylamines of (R) -4- comprises the following steps described in step (1):
A, parabromoacetophenone and ammonium formate reaction obtain the bromo- phenyl ethylamines of 4-, and reaction equation is as follows:
B, using chiral resolving agent the bromo- phenyl ethylamines of 4- split obtaining the bromo- α-phenylethylamines of 4-, reaction equation is as follows:
Preferably, the mol ratio of parabromoacetophenone and ammonium formate described in step A is 1:3.5-1:6, such as 1:3.5、1: 3.8、1:4、1:4.3、1:4.5、1:4.8、1:5、1:5.2、1:5.5、1:5.8 or 1:6.
Preferably, the condition reacted described in step A is:First 110-130 DEG C (such as 110 DEG C, 115 DEG C, 120 DEG C, 125 DEG C or 130 DEG C) under react 2-4 hours (such as 2 hours, 2.5 hours, 3 hours, 3.5 hours or 4 hours), be then warming up to 170-190 DEG C (such as 170 DEG C, 175 DEG C, 180 DEG C, 185 DEG C or 190 DEG C), reaction 4-10 hours (such as 4 hours, 4.5 hours, 5 hours, 5.5 hours, 6 hours, 6.5 hours, 7 hours, 7.5 hours, 8 hours, 8.5 hours, 9 hours, 9.5 hours or 10 are small When).
Preferably, chiral resolving agent described in step B and the mol ratio of the bromo- phenyl ethylamines of 4- are (0.8-1.4):1, such as 0.8: 1、0.9:1、1:1、1.1:1、1.2:1、1.3:1 or 1.4:1, preferably 1:1.
Preferably, chiral resolving agent described in step B is in D- mandelic acids, D- tartaric acid or D- dibenzoyl tartaric acid Any one or at least two combination.
Preferably, the temperature reacted described in step B be 40-80 DEG C, such as 40 DEG C, 45 DEG C, 48 DEG C, 50 DEG C, 55 DEG C, 58 DEG C, 60 DEG C, 65 DEG C, 68 DEG C, 70 DEG C, 75 DEG C, preferably 78 DEG C or 80 DEG C, 60 DEG C.
Preferably, the solvent reacted described in step B is isopropanol, ethanol, dimethylformamide or 1-METHYLPYRROLIDONE In any one or at least two combination.
Preferably, the secondary amino group in step (2) the bromo- 1- methylisoindolines by (R) -5- is protected using tertbutyloxycarbonyl The method of shield is:(R) the bromo- 1- methylisoindolines of -5- are obtained in the presence of organic base with Boc (tertbutyloxycarbonyl) anhydride reaction To the bromo- 1- methylisoindolines of (R)-N-Boc-5-.
Preferably, the described bromo- 1- methylisoindolines of (R) -5- are 1 with the mol ratio of Boc acid anhydrides:(1-1.5), such as 1: 1、1:1.1、1:1.2、1:1.3、1:1.4 or 1:1.5.
Preferably, the organic base is DMAP or the carbon -7- alkene (DBU) of 1,8- diazabicylo 11.
Preferably, temperature of the described bromo- 1- methylisoindolines of (R) -5- in the presence of organic base with Boc anhydride reactions For room temperature.
Preferably, time of the described bromo- 1- methylisoindolines of (R) -5- in the presence of organic base with Boc anhydride reactions For 4-6 hours, such as 4 hours, 4.3 hours, 4.5 hours, 4.8 hours, 5 hours, 5.3 hours, 5.5 hours, 5.8 hours or 6 Hour.
Preferably, the solvent of step (2) described reaction is dichloromethane and/or chloroform.
In the present invention, in structural formula as described above, Me represents methyl.
On the other hand, the invention provides the bromo- 1- first of (R)-N-Boc-5- that preparation method as described above is prepared Base isoindoline.
On the other hand, the invention provides the bromo- 1- first of (R)-N-Boc-5- that preparation method as described above is prepared Application of the base isoindoline in antibacterials preparation.
Preferably, the antibacterials are T-3811.
The bromo- 1- methylisoindolines of (R)-N-Boc-5- that the present invention is prepared can be as antibacterials T-3811 Preparing raw material.
Relative to prior art, the invention has the advantages that:
(1) present invention is produced under lewis acid effect using the bromo- α-phenylethylamines of (R) -4- with polyformaldehyde reaction come closed loop The method of the bromo- 1- methylisoindolines of raw (R) -5-, the cyclic method and step novel and unique, it is easy to operate, yield is higher so that Whole production cost declines to a great extent, the process efficiency greatly improved.
(2) present invention splits the bromo- α-phenylethylamines of preparing raw material (R) -4- for obtaining chirality using resolution reagent first, and then Prepare the bromo- 1- methylisoindolines of (R) -5- so that the scale of construction (volume required for reaction) can be greatly reduced, makes body Amount significantly reduces, and the fractionation of whole process, which is wasted, also significantly to be reduced.
(3) raw material of preparation method of the invention is easy to get, and technological operation is simple, low cost, with higher practical application Value.
Embodiment
Technical scheme is further illustrated below by embodiment.Those skilled in the art should be bright , the embodiment be only to aid in understand the present invention, be not construed as to the present invention concrete restriction.
Embodiment 1
(1) preparation of the bromo- phenyl ethylamines of 4-
Parabromoacetophenone 1000g, ammonium formate 1445g are added in 5L reaction bulb, 120 degree, two originals are slowly heated to Slowly dissolving is in liquid to material, opens stirring, is kept for 120 degree of 2 hours.Then reaction temperature is raised to 180 degree, and is incubated 5 Hour.Stop reaction, after cooling, add water, dichloromethane, layering, organic phase concentration, then add 670 milliliters of concentrated hydrochloric acids and 1000 millis Rise water, backflow, 1-2 hour, reactant first had solid, rear clarification, then a large amount of precipitation solids, and reaction terminates, it is slightly cold after, add 1000 milliliters of toluene, are cooled to room temperature under stirring.Filtering, solid again with toluene is fully washed twice, and solid drying obtains product Hydrochloride, it is neutralized with NaOH, dichloromethane extraction, dries concentration, vacuum distillation obtains 814 grams of sterling, yield 81%.1H NMR(CDCl3,400MHz)1.35(d,3H),1.47(bs,2H),4.09(q,1H),7.22(d,2H),7.44(d, 2H)。
(2) preparation of the bromo- α-phenylethylamines of (R) -4-
600 grams of R-MAs are added in 2900 milliliters of isopropanols, 1500 milliliters of alcohol mixed solutions, are heated to 60 degree, complete Fully dissolved, is slow added into 790 grams of bromo- phenyl ethylamines of 4- (heat release).Room temperature is naturally cooled to, overnight, stirring, filtering drying is obtained 660 grams of crystal.Add it to 2000 milliliters of isopropanols, in 1100 milliliters of alcohol mixed solutions, be heated to 60 degree, crystal is complete Dissolving, is cooled to room temperature, overnight, stirs, filtering, and a small amount of acetone washing, drying obtains 510 grams of crystal.It is used into 4M hydroxides Sodium solution is neutralized to alkalescence, and dichloromethane is extracted three times, and drying is concentrated to give 260.7 grams of colourless liquid, yield 33%.Specific rotation [a]=+ 24 (C1, CDCl3);1H NMR(CDCl3,400MHz)1.35(d,3H),1.47(bs,2H),4.09(q,1H),7.22 (d,2H),7.44(d,2H)。
(3) preparation of the bromo- 3- methylisoindolines of (R) -6-
The bromo- α-phenylethylamines of 200g (R) -4- are dissolved in 3000 milliliters of glacial acetic acid, and 30ml milliliters of trifluoroacetic acids are added dropwise, and reaction is mixed The lower reaction 12 hours of 40 degree of compound.It is concentrated under reduced pressure, residue is dissolved in 3L ethyl acetate, and saturated sodium carbonate solution is washed, washes, does It is dry, it is concentrated under 500 milliliters, stirring and is slowly added to 1000 milliliters of petroleum ethers, be stirred overnight, filter, this step is not purified directly Tap into row next step.
In order to be characterized to its structure, the product of the step is purified into the bromo- 3- methyl iso-indoles of (R) -6- The product of the hydrochloride of quinoline, the nuclear-magnetism characterize data of structure is as follows:1H NMR(CDCl3,400MHz)1.57(d,3H),4.47 (dd,2H),4.82(m,1H),7.31(d,1H),7.58(d,1H),7.67(s,1H),9.86(s,1H),10.36(s,1H)。
(4) preparation of the bromo- 1- methylisoindolines of (R)-N-Boc-5-
150g (R) -6- bromo- 3- methylisoindolines (2000 milliliters) dissolvings of dichloromethane, while adding 4- diformazan ammonia Yl pyridines 3g, stirring is lower to be added dropwise 168g Boc acid anhydrides, reacts at room temperature 3 hours.600 milliliters of saturated sodium bicarbonate solution is added, Solid 3- alanine 15g are added, continue to stir 5 hours.Layering, organic phase dries concentration, residue with ethyl acetate and oil Ether 15 to 1 is recrystallized, and obtains off-white powder 176g, yield 85%.1H NMR(CDCl3,400MHz)1.48(dd,3H), 1.57(s,9H),4.52-4.62(m,1H),4.62-4.76(m,1H),4.92-5.06(m,1H),7.42(dd,1H),7.35 (dd,1H),7.39(s,1H)。
Embodiment 2
(1) preparation of the bromo- phenyl ethylamines of 4-
Parabromoacetophenone 1000g, ammonium formate 950g are added in 5L reaction bulb, 120 degree, two raw materials are slowly heated to Slowly dissolving is in liquid, opens stirring, is kept for 120 degree of 2 hours.Then reaction temperature is raised to 180 degree, and is incubated 5 small When.Stop reaction, after cooling, add water, dichloromethane, layering, organic phase concentration, then add 670 milliliters of concentrated hydrochloric acids and 1000 milliliters Water, backflow, 1-2 hour, reactant first had solid, rear clarification, then a large amount of precipitation solids, and reaction terminates, it is slightly cold after, add 1000 milliliters of toluene, are cooled to room temperature under stirring.Filtering, solid again with toluene is fully washed twice, and solid drying obtains product Hydrochloride, it is neutralized with NaOH, dichloromethane extraction, dries concentration, vacuum distillation obtains 698 grams of sterling, yield 69.4%.1H NMR(CDCl3,400MHz)1.35(d,3H),1.47(bs,2H),4.09(q,1H),7.22(d,2H),7.44 (d,2H)。
(2) preparation of the bromo- α-phenylethylamines of (R) -4-
600 grams of R-MAs are added in 2900 milliliters of isopropanols, 1500 milliliters of alcohol mixed solutions, are heated to 40 degree, complete Fully dissolved, is slow added into the bromo- phenyl ethylamines of 4-, and it is 0.8 with the mol ratio of the bromo- phenyl ethylamines of 4- to make R-MA:1 (heat release).From Room temperature so is cooled to, overnight, stirring, filtering drying obtains 560 grams of crystal.Add it to 2000 milliliters of isopropanols, 1100 millis Rise in alcohol mixed solution, be heated to 60 degree, crystal is completely dissolved, be cooled to room temperature, overnight, stir, filtering, a small amount of acetone is washed Wash, drying obtains 390 grams of crystal.It is neutralized to alkalescence with 4M sodium hydroxide solutions, dichloromethane is extracted three times, dries concentration Obtain 195.2 grams of colourless liquid, yield 24.7%.Specific rotation [a]=+ 24 (C1, CDCl3)。
(3) preparation of the bromo- 3- methylisoindolines of (R) -6-
The bromo- α-phenylethylamines of 200g (R) -4- and 90g paraformaldehydes are dissolved in 3000 milliliters of glacial acetic acid, and 30ml milliliters three are added dropwise Fluoroacetic acid, the lower reaction 12 hours of 40 degree of reactant mixture.It is concentrated under reduced pressure, residue is dissolved in 3L ethyl acetate, and saturated sodium carbonate is molten Liquid is washed, and is washed, and is dried, is concentrated into 500 milliliters, and 2N ether hydrogen chloride solution stirring, after 30 minutes, mistake are slowly added dropwise under stirring Filter, this step, which is not purified, directly carries out next step.
In order to be characterized to its structure, the product of the step is purified into the bromo- 3- methyl iso-indoles of (R) -6- The product of the hydrochloride of quinoline, the nuclear-magnetism characterize data of structure is as follows:1H NMR(CDCl3,400MHz)1.57(d,3H),4.47 (dd,2H),4.82(m,1H),7.31(d,1H),7.58(d,1H),7.67(s,1H),9.86(s,1H),10.36(s,1H)。
(4) preparation of the bromo- 1- methylisoindolines of (R)-N-Boc-5-
150g (R) -6- bromo- 3- methylisoindolines (2000 milliliters) dissolvings of dichloromethane, while adding 4- diformazan ammonia Yl pyridines 3g, stirring is lower to be added dropwise 131g Boc acid anhydrides, reacts at room temperature 3 hours.600 milliliters of saturated sodium bicarbonate solution is added, Solid 3- alanine 5g are added, continue to stir 5 hours.Layering, organic phase dries concentration, residue with ethyl acetate and petroleum ether 15 to 1 are recrystallized, and obtain off-white powder 153g, yield 74%.1H NMR(CDCl3,400MHz)1.48(dd,3H), 1.57(s,9H),4.52-4.62(m,1H),4.62-4.76(m,1H),4.92-5.06(m,1H),7.42(dd,1H),7.35 (dd,1H),7.39(s,1H)。
Embodiment 3
(1) preparation of the bromo- phenyl ethylamines of 4-
Parabromoacetophenone 1000g, ammonium formate 1900g are added in 5L reaction bulb, 120 degree, two originals are slowly heated to Slowly dissolving is in liquid to material, opens stirring, is kept for 120 degree of 2 hours.Then reaction temperature is raised to 180 degree, and is incubated 5 Hour.Stop reaction, after cooling, add water, dichloromethane, layering, organic phase concentration, then add 670 milliliters of concentrated hydrochloric acids and 1000 millis Rise water, backflow, 1-2 hour, reactant first had solid, rear clarification, then a large amount of precipitation solids, and reaction terminates, it is slightly cold after, add 1000 milliliters of toluene, are cooled to room temperature under stirring.Filtering, solid again with toluene is fully washed twice, and solid drying obtains product Hydrochloride, it is neutralized with NaOH, dichloromethane extraction, dries concentration, vacuum distillation obtains 810 grams of sterling, yield 80.6%.1H NMR(CDCl3,400MHz)1.35(d,3H),1.47(bs,2H),4.09(q,1H),7.22(d,2H),7.44 (d,2H)。
(2) preparation of the bromo- α-phenylethylamines of (R) -4-
600 grams of R-MAs are added in 2900 milliliters of isopropanols, 1500 milliliters of alcohol mixed solutions, are heated to 80 degree, complete Fully dissolved, is slow added into the bromo- phenyl ethylamines of 4-, and it is 1.4 with the mol ratio of the bromo- phenyl ethylamines of 4- to make R-MA:1 (heat release).From Room temperature so is cooled to, overnight, stirring, filtering drying obtains 660 grams of crystal.Add it to 2000 milliliters of isopropanols, 1100 millis Rise in alcohol mixed solution, be heated to 60 degree, crystal is completely dissolved, be cooled to room temperature, overnight, stir, filtering, a small amount of acetone is washed Wash, drying obtains 510 grams of crystal.It is neutralized to alkalescence with 4M sodium hydroxide solutions, dichloromethane is extracted three times, dries concentration Obtain 258.8 grams of colourless liquid, yield 32.7%.Specific rotation [a]=+ 24 (C1, CDCl3);1H NMR(CDCl3,400MHz) 1.35(d,3H),1.47(bs,2H),4.09(q,1H),7.22(d,2H),7.44(d,2H)。
(3) preparation of the bromo- 3- methylisoindolines of (R) -6-
The bromo- α-phenylethylamines of 200g (R) -4- and 270g paraformaldehydes are dissolved in 3000 milliliters of glacial acetic acid, are added dropwise 30ml milliliters Trifluoroacetic acid, the lower reaction 12 hours of 40 degree of reactant mixture.It is concentrated under reduced pressure, residue is dissolved in 3L ethyl acetate, saturated sodium carbonate Solution is washed, and is washed, and is dried, is concentrated into 500 milliliters, and 2N ether hydrogen chloride solution stirring is slowly added dropwise under stirring, after 30 minutes, Filtering, this step, which is not purified, directly carries out next step.
In order to be characterized to its structure, the product of the step is purified into the bromo- 3- methyl iso-indoles of (R) -6- The product of the hydrochloride of quinoline, the nuclear-magnetism characterize data of structure is as follows:1H NMR(CDCl3,400MHz)1.57(d,3H),4.47 (dd,2H),4.82(m,1H),7.31(d,1H),7.58(d,1H),7.67(s,1H),9.86(s,1H),10.36(s,1H)。
(4) preparation of the bromo- 1- methylisoindolines of (R)-N-Boc-5-
150g (R) -6- bromo- 3- methylisoindolines (2000 milliliters) dissolvings of dichloromethane, while adding 4- diformazan ammonia Yl pyridines 3g, stirring is lower to be added dropwise 196g Boc acid anhydrides, reacts at room temperature 3 hours.600 milliliters of saturated sodium bicarbonate solution is added, Solid 3- alanine 30g are added, continue to stir 5 hours.Layering, organic phase dries concentration, residue with ethyl acetate and oil Ether 15 to 1 is recrystallized, and obtains off-white powder 175g, yield 84%.1H NMR(CDCl3,400MHz)1.48(dd,3H), 1.57(s,9H),4.52-4.62(m,1H),4.62-4.76(m,1H),4.92-5.06(m,1H),7.42(dd,1H),7.35 (dd,1H),7.39(s,1H)。
Applicant states that the present invention illustrates that the bromo- 1- methyl of (R)-N-Boc-5- of the present invention is different by above-described embodiment Indoline and its preparation method and application, but the invention is not limited in above-described embodiment, that is, do not mean that the present invention must be according to Bad above-described embodiment could be implemented.Person of ordinary skill in the field is it will be clearly understood that any improvement in the present invention, to this hair The equivalence replacement of bright each raw material of product and addition, the selection of concrete mode of auxiliary element etc., all fall within the protection model of the present invention Within the scope of enclosing and disclosing.

Claims (10)

1. the preparation method of one kind bromo- 1- methylisoindolines of (R)-N-Boc-5-, it is characterised in that methods described includes following Step:
(1) the bromo- α-phenylethylamines of (R) -4- lewis acid effect under with polyformaldehyde reaction, obtain the bromo- 1- methyl of (R) -5- different Indoline, reaction equation is as follows:
(2) secondary amino group in the bromo- 1- methylisoindolines of (R) -5- is obtained into (R)-N-Boc-5- using tertbutyloxycarbonyl protection Bromo- 1- methylisoindolines, reaction equation is as follows:
2. preparation method according to claim 1, it is characterised in that step (1) described lewis acid is dilute sulfuric acid, anhydrous In zinc chloride, alchlor, trifluoroacetic acid, titanium tetrachloride or BFEE any one or at least two combination, It is preferred that trifluoroacetic acid;
Preferably, the mol ratio of the bromo- α-phenylethylamines of (R) -4- described in step (1) and paraformaldehyde is 1:(1.5-3);
Preferably, the temperature of step (1) described reaction is 20-60 DEG C.
3. preparation method according to claim 1 or 2, it is characterised in that the solvent of step (1) described reaction is ice vinegar In acid, toluene, benzene or acetonitrile any one or at least two combination;
Preferably, the time of step (1) described reaction is 4-7 hours;
Preferably, step (1) reaction is carried out under protective gas protection, the preferred nitrogen of protective gas.
4. the preparation method according to any one of claim 1-3, it is characterised in that the bromo- α of (R) -4- described in step (1) - Phenyl ethylamine is prepared by raw material of parabromoacetophenone;
Preferably, the preparation method of the bromo- α-phenylethylamines of (R) -4- comprises the following steps described in step (1):
A, parabromoacetophenone and ammonium formate reaction obtain the bromo- phenyl ethylamines of 4-, and reaction equation is as follows:
B, using chiral resolving agent the bromo- phenyl ethylamines of 4- split obtaining the bromo- α-phenylethylamines of 4-, reaction equation is as follows:
5. preparation method according to claim 4, it is characterised in that parabromoacetophenone described in step A and ammonium formate rub You are than being 1:3.5-1:6;
Preferably, the condition reacted described in step A is:Reacted 2-4 hours first at 110-130 DEG C, be then warming up to 170- 190 DEG C, react 4-10 hours.
6. the preparation method according to claim 4 or 5, it is characterised in that chiral resolving agent described in step B is D- almonds In acid, D- tartaric acid or D- dibenzoyl tartaric acids any one or at least two combination;
Preferably, chiral resolving agent described in step B and the mol ratio of the bromo- phenyl ethylamines of 4- are (0.8-1.4):1, preferably 1:1;
Preferably, the solvent reacted described in step B is in isopropanol, ethanol, dimethylformamide or 1-METHYLPYRROLIDONE Any one or at least two combination;
Preferably, the temperature reacted described in step B is 40-80 DEG C, preferably 60 DEG C.
7. the preparation method according to any one of claim 4-6, it is characterised in that step (2) is described bromo- by (R) -5- The method that secondary amino group in 1- methylisoindolines is protected using tertbutyloxycarbonyl is:(R) the bromo- 1- methylisoindolines of -5- exist The bromo- 1- methylisoindolines of (R)-N-Boc-5- are obtained in the presence of organic base with Boc anhydride reactions;
Preferably, the described bromo- 1- methylisoindolines of (R) -5- are 1 with the mol ratio of Boc acid anhydrides:(1-1.5);
Preferably, the organic base is DMAP or the carbon -7- alkene of 1,8- diazabicylo 11;
Preferably, the described bromo- 1- methylisoindolines of (R) -5- are room with the temperature of Boc anhydride reactions in the presence of organic base Temperature;
Preferably, the described bromo- 1- methylisoindolines of (R) -5- are 4- with the time of Boc anhydride reactions in the presence of organic base 6 hours.
8. the preparation method according to any one of claim 4-7, it is characterised in that the solvent of step (2) described reaction For dichloromethane and/or chloroform.
9. the bromo- 1- methyl of (R)-N-Boc-5- that the preparation method according to any one of claim 1-8 is prepared is different Indoline.
10. the bromo- 1- methylisoindolines of (R)-N-Boc-5- according to claim 9 answering in antibacterials preparation With;
Preferably, the antibacterials are T-3811.
CN201710191789.7A 2017-03-28 2017-03-28 Methylisoindoline of 5 bromines of one kind (R) N Boc 1 and its preparation method and application Active CN106957255B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710191789.7A CN106957255B (en) 2017-03-28 2017-03-28 Methylisoindoline of 5 bromines of one kind (R) N Boc 1 and its preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710191789.7A CN106957255B (en) 2017-03-28 2017-03-28 Methylisoindoline of 5 bromines of one kind (R) N Boc 1 and its preparation method and application

Publications (2)

Publication Number Publication Date
CN106957255A true CN106957255A (en) 2017-07-18
CN106957255B CN106957255B (en) 2018-01-09

Family

ID=59470992

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710191789.7A Active CN106957255B (en) 2017-03-28 2017-03-28 Methylisoindoline of 5 bromines of one kind (R) N Boc 1 and its preparation method and application

Country Status (1)

Country Link
CN (1) CN106957255B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110938028A (en) * 2019-12-09 2020-03-31 南京杰运医药科技有限公司 Preparation method of (1R) -5-bromo-2, 3-dihydro-1-methyl-1H-isoindole
CN111718290A (en) * 2020-07-22 2020-09-29 苏州爱玛特生物科技有限公司 Synthesis method of multi-configuration isoindoline-1-carboxylic acid amino acid compound
CN113429333A (en) * 2021-07-08 2021-09-24 江苏法安德医药科技有限公司 Synthesis method of gatifloxacin intermediate

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1195752C (en) * 1997-10-27 2005-04-06 富山化学工业株式会社 Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, solts of 7-isoindo-linequinolonecarboxylic acid, hydrates thereof, and composition contg. same
CN102659675A (en) * 2011-12-27 2012-09-12 盛世泰科生物医药技术(苏州)有限公司 Synthetic method for 6- bromo-2-methyl sulfonyl-1,2,3,4,-tetrahydroisoquinoline
EP2987787A1 (en) * 2013-04-19 2016-02-24 Juntendo Educational Foundation Novel compound with antibacterial activity
WO2016121959A1 (en) * 2015-01-30 2016-08-04 富士フイルム株式会社 Method for producing isoindoline compound or salt thereof, novel isoindoline compound and salt thereof
CN105837555A (en) * 2016-03-31 2016-08-10 南京华威医药科技开发有限公司 Preparation method for garenoxacin and intermediate thereof
WO2017046605A1 (en) * 2015-09-18 2017-03-23 Redx Pharma Plc Antibacterial compounds

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1195752C (en) * 1997-10-27 2005-04-06 富山化学工业株式会社 Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, solts of 7-isoindo-linequinolonecarboxylic acid, hydrates thereof, and composition contg. same
CN102659675A (en) * 2011-12-27 2012-09-12 盛世泰科生物医药技术(苏州)有限公司 Synthetic method for 6- bromo-2-methyl sulfonyl-1,2,3,4,-tetrahydroisoquinoline
EP2987787A1 (en) * 2013-04-19 2016-02-24 Juntendo Educational Foundation Novel compound with antibacterial activity
WO2016121959A1 (en) * 2015-01-30 2016-08-04 富士フイルム株式会社 Method for producing isoindoline compound or salt thereof, novel isoindoline compound and salt thereof
WO2017046605A1 (en) * 2015-09-18 2017-03-23 Redx Pharma Plc Antibacterial compounds
CN105837555A (en) * 2016-03-31 2016-08-10 南京华威医药科技开发有限公司 Preparation method for garenoxacin and intermediate thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
吴孝国,等.: "加雷沙星的合成", 《中国现代应用药学杂志》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110938028A (en) * 2019-12-09 2020-03-31 南京杰运医药科技有限公司 Preparation method of (1R) -5-bromo-2, 3-dihydro-1-methyl-1H-isoindole
CN111718290A (en) * 2020-07-22 2020-09-29 苏州爱玛特生物科技有限公司 Synthesis method of multi-configuration isoindoline-1-carboxylic acid amino acid compound
CN111718290B (en) * 2020-07-22 2022-11-25 苏州爱玛特生物科技有限公司 Synthesis method of multi-configuration isoindoline-1-carboxylic acid amino acid compound
CN113429333A (en) * 2021-07-08 2021-09-24 江苏法安德医药科技有限公司 Synthesis method of gatifloxacin intermediate
CN113429333B (en) * 2021-07-08 2022-03-04 江苏法安德医药科技有限公司 Synthesis method of gatifloxacin intermediate

Also Published As

Publication number Publication date
CN106957255B (en) 2018-01-09

Similar Documents

Publication Publication Date Title
CN103910679B (en) The preparation method of the assorted Shandong of a kind of grace amine
CN106565707B (en) Pa Boxini novel synthesis
CN106957255B (en) Methylisoindoline of 5 bromines of one kind (R) N Boc 1 and its preparation method and application
CN103193849B (en) A kind of preparation method of high-purity Abiraterone acetate
CN103254201B (en) A kind of preparation method of asenapine
CN105198863A (en) Method for preparing high-purity losartan
CN108129258B (en) Synthesis process of 4-bromo-4' -propylbiphenyl
CN109535010B (en) Preparation method of bromhexine hydrochloride
CN102491953A (en) Method for synthesizing florfenicol midbody RT0131
CN110698352B (en) Synthetic method of 3-bromo-5-aminocatechol dimethyl ether
CN105315231A (en) Preparation method of linezolid related substance
CN110790809B (en) Preparation method of abiraterone acetate
CN104447509B (en) A kind of preparation technology of tirofiban hydrochloride
CN102993257A (en) New fulvestrant preparation method
CN112939893B (en) Synthesis method of 4- (4-aminophenyl) -3-morpholinone
CN113045475A (en) Preparation method of 5-bromo-7-methylindole
CN103755657B (en) A kind of preparation method of Rivaroxaban intermediate
CN101412678B (en) Method for synthesizing memantine hydrochloride
CN104387435B (en) Compound and preparation method and application thereof
CN108203455B (en) Method for preparing finasteride by deiodinating dihydrofinasteride iodide
CN102464663B (en) Synthesis method of 1'-tert-butyloxycarbonyl-spiro[chroman-4,4'-piperidine]-2-formic acid
CN103848756B (en) Preparation method of teriflunomide and intermediate thereof
CN105461634A (en) Preparation method of enzalutamide
CN103044345B (en) A kind of synthetic method of 1-(2-hydroxyethyl)-5-sulfydryl-1H-tetrazole
CN106749256B (en) A kind of synthesis technology of entecavir midbodies

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A (R) - n-boc-5-bromo-1-methylisoindoline and its preparation and Application

Effective date of registration: 20200417

Granted publication date: 20180109

Pledgee: Anxin Agricultural Insurance Co., Ltd. Shanghai Minhang Branch Co.

Pledgor: SHANGHAI BALMXY PHARMACEUTICAL Co.,Ltd.

Registration number: Y2020310000010

PC01 Cancellation of the registration of the contract for pledge of patent right
PC01 Cancellation of the registration of the contract for pledge of patent right

Date of cancellation: 20230607

Granted publication date: 20180109

Pledgee: Anxin Agricultural Insurance Co., Ltd. Shanghai Minhang Branch Co.

Pledgor: SHANGHAI BALMXY PHARMACEUTICAL Co.,Ltd.

Registration number: Y2020310000010